Skip to main content
. Author manuscript; available in PMC: 2019 Apr 26.
Published in final edited form as: Best Pract Res Clin Rheumatol. 2018 Apr 26;31(5):676–687. doi: 10.1016/j.berh.2018.03.003

Table 1.

Overview of published papers “Osteoarthritis pain animal models/mouse models” PubMed search Jan 6, 2018.

% Before 2008
(total=36)
% Since 2008
(total=214)
MIA model 41% 54%
Surgical model 28% 33%
Collagenase-induced OA N/A 3%
Other OA-relevant models (ageing, obesity) 3% 3%
Inflammatory models* 16% 6%
Large animals 19% 7%
Two models side-by-side 5% 8%
Includes neurobiology 25% 35%
Assesses more than one behavior 16% 32%
Pain assessed at more than one time point 25% 40%
Assesses pain and joint damage in same animals 33% 43%
DMOAD testing with pain as secondary outcome 5% 11%
*

These include intra-articular administration of CFA or carrageenan in order to trigger joint damage and pain. MIA = mono-iodoacetate; DMOAD = disease-modifying osteoarthritis drug.